n-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide has been researched along with bw 373u86 in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 3 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bolli, R; Kodani, E; Shinmura, K; Takano, H; Tang, XL; Xuan, YT | 1 |
Bolli, R; Nagai, M; Shinmura, K; Tamaki, K; Tani, M | 1 |
Gross, GJ; Hsu, AK; Patel, HH | 1 |
3 other study(ies) available for n-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide and bw 373u86
Article | Year |
---|---|
Delta-opioid receptor-induced late preconditioning is mediated by cyclooxygenase-2 in conscious rabbits.
Topics: 6-Ketoprostaglandin F1 alpha; Animals; Benzamides; Benzylidene Compounds; Celecoxib; Consciousness; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Cyclooxygenase Inhibitors; Dinoprostone; Heart Rate; Ischemic Preconditioning, Myocardial; Isoenzymes; Male; Myocardial Infarction; Myocardial Stunning; Myocardium; Naltrexone; Narcotic Antagonists; Nitrobenzenes; Piperazines; Prostaglandin-Endoperoxide Synthases; Pyrazoles; Rabbits; Receptors, Opioid, delta; Sulfonamides | 2002 |
COX-2-derived prostacyclin mediates opioid-induced late phase of preconditioning in isolated rat hearts.
Topics: 6-Ketoprostaglandin F1 alpha; Animals; Benzamides; Cyclooxygenase 1; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Cyclooxygenase Inhibitors; Dose-Response Relationship, Drug; Epoprostenol; Heart; In Vitro Techniques; Ischemic Preconditioning, Myocardial; Isoenzymes; Male; Membrane Proteins; Myocardial Reperfusion; Myocardium; Narcotics; Nitrobenzenes; Piperazines; Prostaglandin-Endoperoxide Synthases; Pyrazoles; Rats; Rats, Inbred F344; Receptors, Opioid, delta; Sulfonamides; Ventricular Function, Left | 2002 |
COX-2 and iNOS in opioid-induced delayed cardioprotection in the intact rat.
Topics: Analysis of Variance; Animals; Benzamides; Blood Pressure; Cardiotonic Agents; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Cyclooxygenase Inhibitors; Dose-Response Relationship, Drug; Guanidines; Heart Rate; Ischemic Preconditioning, Myocardial; Isoenzymes; Isothiuronium; Male; Myocardial Reperfusion Injury; Myocardium; Nitric Oxide Synthase; Nitric Oxide Synthase Type II; Nitrobenzenes; Piperazines; Prostaglandin-Endoperoxide Synthases; Rats; Rats, Sprague-Dawley; Receptors, Opioid, delta; Sulfonamides | 2004 |